Users Discontinuing Anti-Obesity Injections Put On Pounds Four Times Faster Compared to Those on Conventional Diets

New research reveals that patients who stop using new slimming jabs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end traditional lifestyle programs.

Published data in a major health publication points out that while obese individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month after stopping.

"Users purchasing these medications should be cognizant of the potential of rapid weight regain when the therapy concludes," stated expert Dr. Susan Jebb.

This pace of regain means a reversion to pre-treatment mass in about one and a half years.

Comparing Approaches

The research, which reviewed dozens of trials involving thousands of participants, contrasted the results of the injectable medications with other pills.

Scientists point out that individuals who lose weight through diet and exercise generally see a less rapid creep back—around 0.1 kg a month—once they finish.

Explaining the Fast Rebound

Nutrition scientists propose the mechanism of the jabs accounts for the accelerated regain.

The injections imitate a body's own chemical called GLP-1, which helps regulate appetite.

"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' results in appetite is uncontrolled, making overeating much more probable."

An Ongoing Condition?

Medical guidelines recommend the jabs for people with obesity-related health risks, alongside prescribed lifestyle changes.

Professionals argue that, considering the likelihood of relapse, the therapy should be considered ongoing.

This opinion is supported by pharmaceutical companies, who say that the results "emphasize the long-term character of obesity," comparing it to managing diseases like diabetes.

User Accounts

People who have come off the medication describe a intense return of hunger.

"I experienced something that goes on and I was suddenly starving," said one woman.

The struggle is exacerbated if individuals have not established lasting dietary or behavioural changes during treatment.

Growing Adoption

Survey data show that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

• Adoption is more common among females than males.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion access the drugs through private healthcare rather than the NHS.

Ultimately, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on integrated behavioural changes.